Sano Genetics

This provides access to dynamic health and genetic data for genomics research to accelerate the pace of precision medicine, whilst promoting transparency and data privacy for participants. Anyone can sign up for the platform for free and participants gain access to cutting-edge medical reports on conditions relevant to them receive personalised genetic reports, and have the option to participate in research studies and clinical trials. Sano offers participants full transparency and control over how their data is used.

The company's current focus is on neurological and immune conditions - Parkinson’s Disease, Multiple Sclerosis, and Long COVID, amongst others. Sano expanded its product to be a 'patient portal' for national-scale precision medicine initiatives, such as Genomics England, with the potential to impact millions of people. In 2024, its funding raise of $11.4 million is being channelled into scaling its product to meet demand globally and developing AI integrations.